Copyright Reports & Markets. All rights reserved.

Global Fludeoxyglucose (18F) Radionuclide Injection Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope of Fludeoxyglucose (18F) Radionuclide Injection
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Fludeoxyglucose (18F) Radionuclide Injection Consumption Value by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Sterile
    • 1.3.3 Non-sterile
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Fludeoxyglucose (18F) Radionuclide Injection Consumption Value by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Hospitals
    • 1.4.3 Clinics
    • 1.4.4 Diagnostics Center
  • 1.5 Global Fludeoxyglucose (18F) Radionuclide Injection Market Size & Forecast
    • 1.5.1 Global Fludeoxyglucose (18F) Radionuclide Injection Consumption Value (2019 & 2023 & 2030)
    • 1.5.2 Global Fludeoxyglucose (18F) Radionuclide Injection Sales Quantity (2019-2030)
    • 1.5.3 Global Fludeoxyglucose (18F) Radionuclide Injection Average Price (2019-2030)

2 Manufacturers Profiles

  • 2.1 Zevacor Pharma
    • 2.1.1 Zevacor Pharma Details
    • 2.1.2 Zevacor Pharma Major Business
    • 2.1.3 Zevacor Pharma Fludeoxyglucose (18F) Radionuclide Injection Product and Services
    • 2.1.4 Zevacor Pharma Fludeoxyglucose (18F) Radionuclide Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Zevacor Pharma Recent Developments/Updates
  • 2.2 Queen's PET Imaging
    • 2.2.1 Queen's PET Imaging Details
    • 2.2.2 Queen's PET Imaging Major Business
    • 2.2.3 Queen's PET Imaging Fludeoxyglucose (18F) Radionuclide Injection Product and Services
    • 2.2.4 Queen's PET Imaging Fludeoxyglucose (18F) Radionuclide Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Queen's PET Imaging Recent Developments/Updates
  • 2.3 Triad Isotopes
    • 2.3.1 Triad Isotopes Details
    • 2.3.2 Triad Isotopes Major Business
    • 2.3.3 Triad Isotopes Fludeoxyglucose (18F) Radionuclide Injection Product and Services
    • 2.3.4 Triad Isotopes Fludeoxyglucose (18F) Radionuclide Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Triad Isotopes Recent Developments/Updates
  • 2.4 NCM USA Bronx
    • 2.4.1 NCM USA Bronx Details
    • 2.4.2 NCM USA Bronx Major Business
    • 2.4.3 NCM USA Bronx Fludeoxyglucose (18F) Radionuclide Injection Product and Services
    • 2.4.4 NCM USA Bronx Fludeoxyglucose (18F) Radionuclide Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 NCM USA Bronx Recent Developments/Updates
  • 2.5 Spectron MRC
    • 2.5.1 Spectron MRC Details
    • 2.5.2 Spectron MRC Major Business
    • 2.5.3 Spectron MRC Fludeoxyglucose (18F) Radionuclide Injection Product and Services
    • 2.5.4 Spectron MRC Fludeoxyglucose (18F) Radionuclide Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Spectron MRC Recent Developments/Updates
  • 2.6 Petnet Solutions
    • 2.6.1 Petnet Solutions Details
    • 2.6.2 Petnet Solutions Major Business
    • 2.6.3 Petnet Solutions Fludeoxyglucose (18F) Radionuclide Injection Product and Services
    • 2.6.4 Petnet Solutions Fludeoxyglucose (18F) Radionuclide Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Petnet Solutions Recent Developments/Updates
  • 2.7 Shertech Laboratories
    • 2.7.1 Shertech Laboratories Details
    • 2.7.2 Shertech Laboratories Major Business
    • 2.7.3 Shertech Laboratories Fludeoxyglucose (18F) Radionuclide Injection Product and Services
    • 2.7.4 Shertech Laboratories Fludeoxyglucose (18F) Radionuclide Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Shertech Laboratories Recent Developments/Updates
  • 2.8 Precision Nuclear
    • 2.8.1 Precision Nuclear Details
    • 2.8.2 Precision Nuclear Major Business
    • 2.8.3 Precision Nuclear Fludeoxyglucose (18F) Radionuclide Injection Product and Services
    • 2.8.4 Precision Nuclear Fludeoxyglucose (18F) Radionuclide Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 Precision Nuclear Recent Developments/Updates

3 Competitive Environment: Fludeoxyglucose (18F) Radionuclide Injection by Manufacturer

  • 3.1 Global Fludeoxyglucose (18F) Radionuclide Injection Sales Quantity by Manufacturer (2019-2024)
  • 3.2 Global Fludeoxyglucose (18F) Radionuclide Injection Revenue by Manufacturer (2019-2024)
  • 3.3 Global Fludeoxyglucose (18F) Radionuclide Injection Average Price by Manufacturer (2019-2024)
  • 3.4 Market Share Analysis (2023)
    • 3.4.1 Producer Shipments of Fludeoxyglucose (18F) Radionuclide Injection by Manufacturer Revenue ($MM) and Market Share (%): 2023
    • 3.4.2 Top 3 Fludeoxyglucose (18F) Radionuclide Injection Manufacturer Market Share in 2023
    • 3.4.2 Top 6 Fludeoxyglucose (18F) Radionuclide Injection Manufacturer Market Share in 2023
  • 3.5 Fludeoxyglucose (18F) Radionuclide Injection Market: Overall Company Footprint Analysis
    • 3.5.1 Fludeoxyglucose (18F) Radionuclide Injection Market: Region Footprint
    • 3.5.2 Fludeoxyglucose (18F) Radionuclide Injection Market: Company Product Type Footprint
    • 3.5.3 Fludeoxyglucose (18F) Radionuclide Injection Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Fludeoxyglucose (18F) Radionuclide Injection Market Size by Region
    • 4.1.1 Global Fludeoxyglucose (18F) Radionuclide Injection Sales Quantity by Region (2019-2030)
    • 4.1.2 Global Fludeoxyglucose (18F) Radionuclide Injection Consumption Value by Region (2019-2030)
    • 4.1.3 Global Fludeoxyglucose (18F) Radionuclide Injection Average Price by Region (2019-2030)
  • 4.2 North America Fludeoxyglucose (18F) Radionuclide Injection Consumption Value (2019-2030)
  • 4.3 Europe Fludeoxyglucose (18F) Radionuclide Injection Consumption Value (2019-2030)
  • 4.4 Asia-Pacific Fludeoxyglucose (18F) Radionuclide Injection Consumption Value (2019-2030)
  • 4.5 South America Fludeoxyglucose (18F) Radionuclide Injection Consumption Value (2019-2030)
  • 4.6 Middle East and Africa Fludeoxyglucose (18F) Radionuclide Injection Consumption Value (2019-2030)

5 Market Segment by Type

  • 5.1 Global Fludeoxyglucose (18F) Radionuclide Injection Sales Quantity by Type (2019-2030)
  • 5.2 Global Fludeoxyglucose (18F) Radionuclide Injection Consumption Value by Type (2019-2030)
  • 5.3 Global Fludeoxyglucose (18F) Radionuclide Injection Average Price by Type (2019-2030)

6 Market Segment by Application

  • 6.1 Global Fludeoxyglucose (18F) Radionuclide Injection Sales Quantity by Application (2019-2030)
  • 6.2 Global Fludeoxyglucose (18F) Radionuclide Injection Consumption Value by Application (2019-2030)
  • 6.3 Global Fludeoxyglucose (18F) Radionuclide Injection Average Price by Application (2019-2030)

7 North America

  • 7.1 North America Fludeoxyglucose (18F) Radionuclide Injection Sales Quantity by Type (2019-2030)
  • 7.2 North America Fludeoxyglucose (18F) Radionuclide Injection Sales Quantity by Application (2019-2030)
  • 7.3 North America Fludeoxyglucose (18F) Radionuclide Injection Market Size by Country
    • 7.3.1 North America Fludeoxyglucose (18F) Radionuclide Injection Sales Quantity by Country (2019-2030)
    • 7.3.2 North America Fludeoxyglucose (18F) Radionuclide Injection Consumption Value by Country (2019-2030)
    • 7.3.3 United States Market Size and Forecast (2019-2030)
    • 7.3.4 Canada Market Size and Forecast (2019-2030)
    • 7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe

  • 8.1 Europe Fludeoxyglucose (18F) Radionuclide Injection Sales Quantity by Type (2019-2030)
  • 8.2 Europe Fludeoxyglucose (18F) Radionuclide Injection Sales Quantity by Application (2019-2030)
  • 8.3 Europe Fludeoxyglucose (18F) Radionuclide Injection Market Size by Country
    • 8.3.1 Europe Fludeoxyglucose (18F) Radionuclide Injection Sales Quantity by Country (2019-2030)
    • 8.3.2 Europe Fludeoxyglucose (18F) Radionuclide Injection Consumption Value by Country (2019-2030)
    • 8.3.3 Germany Market Size and Forecast (2019-2030)
    • 8.3.4 France Market Size and Forecast (2019-2030)
    • 8.3.5 United Kingdom Market Size and Forecast (2019-2030)
    • 8.3.6 Russia Market Size and Forecast (2019-2030)
    • 8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific

  • 9.1 Asia-Pacific Fludeoxyglucose (18F) Radionuclide Injection Sales Quantity by Type (2019-2030)
  • 9.2 Asia-Pacific Fludeoxyglucose (18F) Radionuclide Injection Sales Quantity by Application (2019-2030)
  • 9.3 Asia-Pacific Fludeoxyglucose (18F) Radionuclide Injection Market Size by Region
    • 9.3.1 Asia-Pacific Fludeoxyglucose (18F) Radionuclide Injection Sales Quantity by Region (2019-2030)
    • 9.3.2 Asia-Pacific Fludeoxyglucose (18F) Radionuclide Injection Consumption Value by Region (2019-2030)
    • 9.3.3 China Market Size and Forecast (2019-2030)
    • 9.3.4 Japan Market Size and Forecast (2019-2030)
    • 9.3.5 Korea Market Size and Forecast (2019-2030)
    • 9.3.6 India Market Size and Forecast (2019-2030)
    • 9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
    • 9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America

  • 10.1 South America Fludeoxyglucose (18F) Radionuclide Injection Sales Quantity by Type (2019-2030)
  • 10.2 South America Fludeoxyglucose (18F) Radionuclide Injection Sales Quantity by Application (2019-2030)
  • 10.3 South America Fludeoxyglucose (18F) Radionuclide Injection Market Size by Country
    • 10.3.1 South America Fludeoxyglucose (18F) Radionuclide Injection Sales Quantity by Country (2019-2030)
    • 10.3.2 South America Fludeoxyglucose (18F) Radionuclide Injection Consumption Value by Country (2019-2030)
    • 10.3.3 Brazil Market Size and Forecast (2019-2030)
    • 10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa

  • 11.1 Middle East & Africa Fludeoxyglucose (18F) Radionuclide Injection Sales Quantity by Type (2019-2030)
  • 11.2 Middle East & Africa Fludeoxyglucose (18F) Radionuclide Injection Sales Quantity by Application (2019-2030)
  • 11.3 Middle East & Africa Fludeoxyglucose (18F) Radionuclide Injection Market Size by Country
    • 11.3.1 Middle East & Africa Fludeoxyglucose (18F) Radionuclide Injection Sales Quantity by Country (2019-2030)
    • 11.3.2 Middle East & Africa Fludeoxyglucose (18F) Radionuclide Injection Consumption Value by Country (2019-2030)
    • 11.3.3 Turkey Market Size and Forecast (2019-2030)
    • 11.3.4 Egypt Market Size and Forecast (2019-2030)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
    • 11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics

  • 12.1 Fludeoxyglucose (18F) Radionuclide Injection Market Drivers
  • 12.2 Fludeoxyglucose (18F) Radionuclide Injection Market Restraints
  • 12.3 Fludeoxyglucose (18F) Radionuclide Injection Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Fludeoxyglucose (18F) Radionuclide Injection and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Fludeoxyglucose (18F) Radionuclide Injection
  • 13.3 Fludeoxyglucose (18F) Radionuclide Injection Production Process
  • 13.4 Fludeoxyglucose (18F) Radionuclide Injection Industrial Chain

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Fludeoxyglucose (18F) Radionuclide Injection Typical Distributors
  • 14.3 Fludeoxyglucose (18F) Radionuclide Injection Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Fludeoxyglucose (18F) Radionuclide Injection market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
    Fludeoxyglucose (18F) radionuclide injection is radioactive substance used for diagnostic purpose with Positron Emission Tomography (PET).
    Advancement in radiopharmaceutical technologies along with more improve hardware and software of PET imaging are the primary factors driving the growth of Fludeoxyglucose (18F) Radionuclide Injection market.
    The Global Info Research report includes an overview of the development of the Fludeoxyglucose (18F) Radionuclide Injection industry chain, the market status of Hospitals (Sterile, Non-sterile), Clinics (Sterile, Non-sterile), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Fludeoxyglucose (18F) Radionuclide Injection.
    Regionally, the report analyzes the Fludeoxyglucose (18F) Radionuclide Injection markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Fludeoxyglucose (18F) Radionuclide Injection market, with robust domestic demand, supportive policies, and a strong manufacturing base.
    Key Features:
    The report presents comprehensive understanding of the Fludeoxyglucose (18F) Radionuclide Injection market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Fludeoxyglucose (18F) Radionuclide Injection industry.
    The report involves analyzing the market at a macro level:
    Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (Kg), revenue generated, and market share of different by Type (e.g., Sterile, Non-sterile).
    Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Fludeoxyglucose (18F) Radionuclide Injection market.
    Regional Analysis: The report involves examining the Fludeoxyglucose (18F) Radionuclide Injection market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
    Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Fludeoxyglucose (18F) Radionuclide Injection market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
    The report also involves a more granular approach to Fludeoxyglucose (18F) Radionuclide Injection:
    Company Analysis: Report covers individual Fludeoxyglucose (18F) Radionuclide Injection manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
    Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Fludeoxyglucose (18F) Radionuclide Injection This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals, Clinics).
    Technology Analysis: Report covers specific technologies relevant to Fludeoxyglucose (18F) Radionuclide Injection. It assesses the current state, advancements, and potential future developments in Fludeoxyglucose (18F) Radionuclide Injection areas.
    Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Fludeoxyglucose (18F) Radionuclide Injection market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
    Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
    Market Segmentation
    Fludeoxyglucose (18F) Radionuclide Injection market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
    Market segment by Type
    Sterile
    Non-sterile
    Market segment by Application
    Hospitals
    Clinics
    Diagnostics Center
    Major players covered
    Zevacor Pharma
    Queen's PET Imaging
    Triad Isotopes
    NCM USA Bronx
    Spectron MRC
    Petnet Solutions
    Shertech Laboratories
    Precision Nuclear
    Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Fludeoxyglucose (18F) Radionuclide Injection product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Fludeoxyglucose (18F) Radionuclide Injection, with price, sales, revenue and global market share of Fludeoxyglucose (18F) Radionuclide Injection from 2019 to 2024.
    Chapter 3, the Fludeoxyglucose (18F) Radionuclide Injection competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Fludeoxyglucose (18F) Radionuclide Injection breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
    Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Fludeoxyglucose (18F) Radionuclide Injection market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
    Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Fludeoxyglucose (18F) Radionuclide Injection.
    Chapter 14 and 15, to describe Fludeoxyglucose (18F) Radionuclide Injection sales channel, distributors, customers, research findings and conclusion.

    Buy now